migraine relief (63941-205)

Drug Facts

Product Profile

Brand Name migraine relief

Generic Name acetaminophen, aspirin and caffeine

Labeler valu merchandisers company

Dosage Form TABLET

Routes

ORAL

Active Ingredients

acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1

Manufacturer

VALU MERCHANDISERS COMPANY

Identifiers & Regulatory

Product NDC 63941-205

Product ID 63941-205_45b24d62-afd1-0246-e063-6294a90a3729

Product Type HUMAN OTC DRUG

Marketing Category ANDA

Application Number ANDA214039

Marketing Start 2024-01-11

Marketing End 2026-03-31

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs] xanthines [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63941205

Hyphenated Format 63941-205

Supplemental Identifiers

RxCUI

308297

UPC

0070038667308

UNII

362O9ITL9D R16CO5Y76E 3G6A5W338E

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name migraine relief (source: ndc)

Generic Name acetaminophen, aspirin and caffeine (source: ndc)

Application Number ANDA214039 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

250 mg/1
65 mg/1

source: ndc

Packaging

1 BOTTLE, PLASTIC in 1 CARTON (63941-205-01) / 24 TABLET in 1 BOTTLE, PLASTIC

source: ndc

Packages (1)

63941-205-01 1 BOTTLE, PLASTIC in 1 CARTON (63941-205-01) / 24 TABLET in 1 BOTTLE, PLASTIC

Ingredients (3)

acetaminophen (250 mg/1) aspirin (250 mg/1) caffeine (65 mg/1)

Linked Drug Pages (1)

Migraine Relief ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "45b24d62-afd1-0246-e063-6294a90a3729", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0070038667308"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["0c3d52c6-b292-2315-e063-6294a90a6361"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["VALU MERCHANDISERS COMPANY"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63941-205-01)  / 24 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "63941-205-01", "marketing_end_date": "20260331", "marketing_start_date": "20240111"}], "brand_name": "Migraine Relief", "product_id": "63941-205_45b24d62-afd1-0246-e063-6294a90a3729", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "63941-205", "generic_name": "ACETAMINOPHEN, ASPIRIN and CAFFEINE", "labeler_name": "VALU MERCHANDISERS COMPANY", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Migraine Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA214039", "marketing_category": "ANDA", "marketing_end_date": "20260331", "marketing_start_date": "20240111"}